During the global coronavirus outbreak, our key priority is to safeguard the health and wellbeing of our employees, partners, clients, community members, and, of course, our family members and friends. In addition to doing our part to flatten the curve, we have also taken the necessary operational measures to guarantee everyone's availability to serve our clients, many of whom are taking a direct and active role in treating the pandemic. Our team remains 100% operational during this time.
Click here for contact information >

X

blog

Industry insights from our own scientists, publicists, developers, designers, strategists and more.

Our experts have spent their careers learning their craft, honing their skills and implementing the most effective marketing, engagement and public relations strategies to help healthcare and science brands transform the world. Let's dive in, shall we?

Our latest posts

A Few 2019 Wraps and 2020 Trends to Watch

We've brought together a few of our favorite year-end wrap-ups and some 2020 predictions for digital and life sciences.

FDA

Deliver a Successful Investor Presentation

Does your investor presentation clearly articulate your passion, commitment and value in 20 minutes or less? The development and delivery of a presentation plays a critical part in getting the attention you want and deserve. Every company has a different story to tell, but most of the time the presentations are in the same format, in the same room, and to the same people. Our team has had the privilege of watching and developing biotech company presentations for over 15 years.

Corporate Communications

Networked & Personalized - the future of biotech?

During BIO2012 last week, Ernst & Young presented their annual Beyond Borders report on the state of the biotech industry. Several themes are covered in the report but the underlying trend is a much broader discussion and movement towards open sharing of data and collaboration across academia, industry, patient advocacy groups and payors. This "networked innovation" aligns biotech with high tech's much broader use of data and personalized targeting that we see at work in social networks and online advertsing every day and has enormous opportunity to increase timelines and success rates in drug development.

Biotech

Spring time = launch time!

With FDA and EMA reviews and decisions pending for many of our clients we are working on global launch strategies to support commercial and corporate teams as they gear up for product approval across multiple countries.

Communication Plan

Mobilize your marketing

Smartphones are quickly becoming a way of life for medical professionals. An ongoing Knowledge Networks survey showed that in 2010 62% of specialists and 55% of primary care physicians own a smart phone, with 85% to 90% using them to access the Internet or email.

Marketing